Kenneth C. Cundy, SVP, Preclinical Development at XENOPORT INC (XNPT), sold 100 shares at $27.32 ($3K) on 2009-01-02, disclosed to the SEC on 2009-01-06.
Scheduled sale ($3k) by SVP, Preclinical Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CWBR | SELL | 2020-08-10 | $19K | — | Filing → |
| CWBR | SELL | 2020-06-17 | $24K | — | Filing → |
| CWBR | SELL | 2020-05-18 | $26K | — | Filing → |